FABP3 Polyclonal Antibody

422 protein, Cardiac Fatty Acid Binding Protein, FABP 11, FABP 3, FABP11, FABP3, FABPH, Fatty acid binding protein 11, Fatty acid binding protein 3, Fatty acid binding protein 3 muscle and heart, Fatty acid binding protein 3 muscle and heart mammary derived growth inhibitor, Fatty acid binding protein 3 muscle, Fatty acid binding protein 3, muscle and heart (mammary derived growth inhibitor), Fatty acid binding protein 3, muscle, Fatty acid binding protein heart, Fatty acid binding protein, heart, Fatty acid binding protein, muscle and heart, Fatty acid binding protein, skeletal muscle, Fatty acid-binding protein 3, Fatty acid-binding protein, H FABP, H-FABP, heart, Heart type fatty acid binding protein, Heart-type fatty acid-binding protein, M FABP, M-FABP, Mammary derived growth inhibitor, Mammary-derived growth inhibitor, MDGI, Muscle fatty acid binding protein, Muscle fatty acid-binding protein, Mylein protein P2 homolog, O FABP, OTTHUMP00000003898, P2 adopocyte protein

The intracellular fatty acid-binding proteins (FABPs) belongs to a multigene family. FABPs are divided into at least three distinct types, namely the hepatic-, intestinal- and cardiac-type. They form 14-15 kDa proteins and are thought to participate in the uptake, intracellular metabolism and/or transport of long-chain fatty acids. They may also be responsible in the modulation of cell growth and proliferation. Fatty acid-binding protein 3 gene contains four exons and its function is to arrest growth of mammary epithelial cells. This gene is a candidate tumor suppressor gene for human breast cancer. Alternative splicing results in multiple transcript variants.

Store at -20C. Avoid freeze / thaw cycles.

PBS with 0.02% sodium azide and 50% glycerol pH 7.4.

WB 1:500 - 1:2000 IHC 1:50 - 1:200 IF 1:50 - 1:200

14kDa